In the context of non-overweight GLP-1 therapy, these genetic predispositions may help provide context around metabolic responsiveness and appetite regulationthough genetic status does not predict exact medication response and should be interpreted with a qualified healthcare provider
Transcytosis assay in an in vitro model of the BBB bEnd.3 cells were inoculated into 24-well Transwell plates and incubated
It plays a key role in glucose and appetite regulation by: Stimulating insulin release (glucose-dependent) Suppressing glucagon secretion Slowing gastric emptying Increasing satiety and reducing appetite In people with type 2 diabetes, this GLP-1 response is impaired leading to poor glycemic control
The improved blood flow helps clear inflammatory debris and brings in the building blocks needed for tissue repair
Its crucial to keep in mind that whilst these drugs can support weight loss attempts, they arent a quick fix
Eight to ten days after differentiation, the differentiated adipocytes were stained with BODIPY (Sigma-Aldrich) or collected for RNA and protein extraction